Author

Dimitros Mougiakakos

Health Campus for Inflammation, Immunity and Infection (GCI3), Otto-von-Guericke University of Magdeburg

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Filippo Frioni· 1 shared Francesca SaccoiD· 1 shared Gerardo Pepe· 1 shared Gessica Minnella· 1 shared Giorgia MassacciiD· 1 shared Giusj Monia Pugliese· 1 shared John Donald Marra· 1 shared Livia PerfettoiD· 1 shared

Activity by Year

2023-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Filippo Frioni

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivJun 22, 2023

Unveiling the signaling network of FLT3-ITD AML improves drug sensitivity prediction

Sara Latini, Veronica Venafra, Giorgia Massacci…·Francesca Sacco

This study develops a systems-based strategy to predict drug sensitivity in FLT3-ITD AML by integrating genomic, transcriptomic data with a prior-knowledge signaling network.

DOI 10.7554/elife.90532.3

humanbulk RNA-seq

𝕏 PostBluesky